<DOC>
	<DOCNO>NCT01106716</DOCNO>
	<brief_summary>The purpose study determine whether KAI-1678 effective treatment postherpetic neuralgia pain</brief_summary>
	<brief_title>Safety Efficacy Study KAI-1678 Treat Pain Subjects With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>diagnosis PHN pain least 3 month segmental herpes zoster eruption pain score least 4 11point numerical rating scale ( 010 ) stable dos analgesic medication least 1 month '' diagnosis PHN pain least 3 month segmental herpes zoster eruption pain score least 4 11point numerical rating scale ( 010 ) stable dos analgesic medication least 1 month ''</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Lidocaine</keyword>
	<keyword>Lignocaine</keyword>
	<keyword>Analgesics . Non-narcotic / therapeutic use</keyword>
	<keyword>Neuralgia , Postherpetic</keyword>
	<keyword>Pain</keyword>
	<keyword>Pain measurement / drug effect</keyword>
	<keyword>Pain postoperative / drug therapy</keyword>
	<keyword>PHN</keyword>
</DOC>